Glioblastoma Recurrent

• CLINICAL_TRIALS research · 2026-04-01
  Clinical Trial Update: Testing the Addition of the Immune Therapy Drugs, Tocilizumab and Atezolizumab, to Radiation Therapy for Recurrent Glioblastoma [Phase 2]

  This is a Phase 2 clinical trial update evaluating the addition of immune therapies Tocilizumab and Atezolizumab to radiation therapy for re…

• CLINICAL_TRIALS research · 2024-11-19
  Clinical Trial Update: Retifanlimab with Bevacizumab and Hypofractionated Radiotherapy for the Treatment of Recurrent Glioblastoma [Phase 2]

  A Phase 2 clinical trial is evaluating retifanlimab in combination with bevacizumab and hypofractionated radiotherapy for recurrent glioblas…

• CLINICAL_TRIALS trial_result · 2024-10-15
  Clinical Trial Update: Study of Recombinant Human Endostatin Combined with Temozolomide and Irinotecan in Recurrent Gliomas [Phase 2]

  A Phase 2 clinical trial evaluating the combination of recombinant human endostatin with temozolomide and irinotecan for recurrent gliomas i…